Home » Topics » BioWorld Science

BioWorld Science
RSS

Arcutis begins phase II study of ARQ-154 foam for seborrheic dermatitis

Nov. 21, 2019

New phase I study evaluates bispecific PSMAxCD3 antibody CC-1 in CRPC

Nov. 21, 2019

FDA approves Givlaari for acute hepatic porphyria

Nov. 21, 2019

Kinnate Biopharma patents CDK inhibitors

Nov. 21, 2019

Enanta Pharmaceuticals describes new MAP3K5 inhibitors

Nov. 21, 2019

Rigel Pharmaceuticals synthesizes RIPK1 inhibitors

Nov. 21, 2019

Bristol-Myers Squibb discloses new UFO and MERTK inhibitors

Nov. 21, 2019

Eternity Bioscience patents RORC antagonists

Nov. 21, 2019

L-FABP levels correlated with sarcopenia measures in diabetic kidney disease

Nov. 21, 2019

Data on peripheral immune responses to selgantolimod from phase II study in HBV reported

Nov. 21, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026